Date: 2014-07-16 01:09:14Multiple sclerosis Immune system Autoimmune diseases Natalizumab Treatment of multiple sclerosis Progressive multifocal leukoencephalopathy Fingolimod JC virus Glatiramer acetate Immunology Medicine Immunosuppressants | | Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium IMI PROTECT WP5 IMI Report 2:b:iv NATALIZUMAB WAVE 2 CASE STUDY REPORT Review of methodologies for benefit andAdd to Reading ListSource URL: protectbenefitrisk.euDownload Document from Source Website File Size: 3,16 MBShare Document on Facebook
|